Anxiety treatment in the US is on the verge of a breakthrough after almost twenty years of no new class of anti, anxiety drugs. People with anxiety disorders had to use the same limited set of therapeutic methods for years: SSRIs, benzodiazepines, and talk therapy. While these therapies are efficacious for the majority, there are still some patients who struggle with the side effects of the drugs, complete relief not being attained, or getting therapy after a prolonged waiting period. Presently, a wave of clinical research is changing the face of anxiety treatment and offering a new lease of life to those who may have felt they had run out of options.
One of the significant breakthroughs in anxiety therapy is related to psychedelic, based therapies. Phase 2 trials of MM120, a compound derived from LSD, provide that a single dose along with supportive care may drastically lessen symptoms of generalized anxiety for a few weeks. The evidence is so strong that it warrants Phase 3 trials thus the US is only a step away from releasing a new class of anxiety medication after almost two decades. Alongside this, psilocybin, assisted therapy research proposes that, through psychedelic sessions under a guide, people may be able to change their perception of the fear and anxiety instead of it being just a suppression of the symptoms.
Besides LSD, other such non, psychedelic drugs are also being developed for the treatment of anxiety. For instance, an antianxiety drug for social anxiety disorder called BNC210 seems to act very quickly in lowering symptoms and does not have side effects like drowsiness or risk of addiction which are typically associated with old drugs. Also, there are a few more candidates which are being developed experimentally to promote brain plasticity, alter serotonin in such a manner that is more controlled, or simply quiet hyperactivated fear circuits. They all aim for making anxiety treatments safer, quicker, and longer, lasting.
At the same time, these innovations also blend with major mental health patterns which are personalized medicine and digital tools. It is highly likely that in the near future, treating anxiety may involve the use of a certain drug or therapy alongside data obtained from wearables, symptom tracking through apps, and AI, based devices that assist clinicians in determining care. Most importantly, the experts emphasize that it is the aspect of human contact which is the main focus of therapy. At any rate, no matter to what extent anxiety treatments are advanced, people still require therapists, peers, and supportive communities for them to be able to make sense of their experiences and effect long, term changes.
Nevertheless, there are still challenges such as regulatory approval, affordability, and equitable access which remain unresolved issues. However, the drive behind the new anxiety treatment methods is a sign of a more hopeful future, especially for those who have been through “everything” and are still in the process of looking for relief.
Source: Compass Associates – How new research approaches could transform anxiety treatment
Leave a Comment